M&A Deal Summary |
|
|---|---|
| Date | 2015-07-24 |
| Target | Zhejiang Wansheng Pharmaceutical Co. |
| Sector | Life Science |
| Buyer(s) | 3SBio |
| Deal Type | Add-on Acquisition |
| Deal Value | 528M CNY |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1993 |
| Sector | Life Science |
| Employees | 6,268 |
| Revenue | 9.1B CNY (2024) |
3SBio is a biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products. 3SBio was incorporated in 1993 and is based in Shenyang, China.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: China M&A | 1 of 1 |
| Year: 2015 M&A | 2 of 2 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-01-26 |
Sirton Pharmaceuticals
Villa Guardia, Italy Sirton Pharmaceuticals SpA is a pharmaceutical contract manufacturing company located in Villa Guardia, near Cuomo, Italy. Sirton produces injectable pharma products, including pre-filled syringes, liquid vials, freeze-dried vials and ampoules, and pharmaceutical development services including lyophilization process development, analytical method development and validation, stability studies and manufacturing of clinical study materials. |
Buy | - |
